Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

1,466 public trials 175 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

S0528 Lapatinib and Everolimus in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma

NCT00352443

Conditions
Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +43 more
Locations
  • USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
  • University of California Davis Cancer Center Sacramento, California, United States
  • University of Colorado Cancer Center at UC Health Sciences Center Aurora, Colorado, United States
  • Lucille P. Markey Cancer Center at University of Kentucky Lexington, Kentucky, United States
View Trial Details
Completed

Combination Chemotherapy in Treating Younger Patients With Hodgkin Lymphoma

NCT00666484

Conditions
Chemically-Induced Disorders, Hemic and Lymphatic Diseases, Hodgkin Disease, +11 more
Locations
  • Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom
  • University College Hospital - London London, England, United Kingdom
  • King's College Hospital London, England, United Kingdom
  • Northern Centre for Cancer Treatment at Newcastle General Hospital Newcastle upon Tyne, England, United Kingdom
View Trial Details
Completed

Gemcitabine Hydrochloride, Cyclophosphamide, Vincristine Sulfate, Prednisolone, and Rituximab in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma

NCT00971763

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Sussex Cancer Centre at Royal Sussex County Hospital Brighton, England, United Kingdom
  • Leeds General Infirmary Leeds, England, United Kingdom
  • Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom
  • Cancer Research UK and University College London Cancer Trials Centre London, England, United Kingdom
View Trial Details
Completed

Gemcitabine and Bexarotene in Treating Patients With Progressive or Refractory Stage IB, Stage II, Stage III, or Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma

NCT00660231

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations
  • Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom
  • Saint Bartholomew's Hospital London, England, United Kingdom
  • St. Thomas' Hospital London, England, United Kingdom
  • Christie Hospital Manchester, England, United Kingdom
View Trial Details

Related conditions